Todays Report: Today, Weekly Investment Analysts’ Ratings Updates for Gilead Sciences (GILD)

Today, Weekly Investment Analysts’ Ratings Updates for Gilead Sciences (GILD)

A number of firms have modified their ratings and price targets on shares of Gilead Sciences (NASDAQ: GILD) recently:

Shares of Gilead Sciences Inc. (NASDAQ:GILD) opened at 75.30 on Friday. Gilead Sciences Inc. has a one year low of $71.39 and a one year high of $108.63. The company’s 50 day moving average price is $74.67 and its 200 day moving average price is $80.27. The stock has a market capitalization of $99.20 billion, a price-to-earnings ratio of 6.96 and a beta of 1.25.

Gilead Sciences (NASDAQ:GILD) last posted its quarterly earnings data on Tuesday, November 1st. The biopharmaceutical company reported $2.75 earnings per share for the quarter, missing the consensus estimate of $2.87 by $0.12. Gilead Sciences had a return on equity of 100.57% and a net margin of 47.74%. The company earned $7.40 billion during the quarter, compared to the consensus estimate of $7.47 billion. During the same quarter last year, the firm earned $3.22 EPS. The business’s revenue for the quarter was down 9.6% on a year-over-year basis. On average, analysts expect that Gilead Sciences Inc. will post $11.47 earnings per share for the current fiscal year.

The firm also recently announced a quarterly dividend, which will be paid on Thursday, December 29th. Shareholders of record on Thursday, December 15th will be issued a dividend of $0.47 per share. This represents a $1.88 dividend on an annualized basis and a yield of 2.50%. The ex-dividend date of this dividend is Tuesday, December 13th. Gilead Sciences’s dividend payout ratio is presently 17.44%.

Related posts

Leave a Comment